🇺🇸 FDA
Patent

US 7838511

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers

granted A61KA61K31/16A61K31/19

Quick answer

US patent 7838511 (Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers) held by The Board of Regents of the University of Texas System expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/16, A61K31/19, A61K31/60, A61K31/685